Literature DB >> 4284222

In vitro demonstration of vascular hyper-responsiveness in experimental hypertension.

J A Hinke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4284222     DOI: 10.1161/01.res.17.4.359

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  8 in total

1.  Comparison of the visco-elastic properties of the tail artery in spontaneously hypertensive and normotensive rats.

Authors:  R Busse; R D Bauer; Y Summa; H Körner; T Pashch
Journal:  Pflugers Arch       Date:  1976-07-30       Impact factor: 3.657

Review 2.  Digitalislike circulating factor in hypertension: potential messenger between salt balance and intracellular sodium.

Authors:  F J Haddy
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

3.  Vascular reactivity to 5-hydroxytryptamine and hypertension in the rat.

Authors:  G Haeusler; L Finch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Vascular reactivity to noradrenaline and 5-hydroxytryptamine in hypertensive rats.

Authors:  J M Armstrong
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

5.  Central adrenergic neurones and the initiation and development of experimental hypertension.

Authors:  G Haeusler; L Finch; H Thoenen
Journal:  Experientia       Date:  1972-10-15

6.  Humoral factors and the sodium-potassium pump in low renin hypertension.

Authors:  F J Haddy
Journal:  Klin Wochenschr       Date:  1982-10-01

7.  Corticosteroid involvement in the changes in noradrenergic responsiveness of tissues from rats made hypertensive by short-term isolation.

Authors:  T Bennett; S M Gardiner
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

8.  Effect of sodium, deoxycorticosterone and duration of hypertension on pressor responses in rats.

Authors:  R F Bing; G I Russell; J D Swales; H Thurston
Journal:  J Physiol       Date:  1982-12       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.